{
    "organizations": [],
    "uuid": "097f41b60e13f17ca34453d04d48c419c983eb7d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-says-on-april/brief-dova-pharmaceuticals-says-on-april-17-co-unit-and-svb-entered-loan-and-security-agreement-idUSFWN1RX0N3",
    "ord_in_thread": 0,
    "title": "BRIEF-Dova Pharmaceuticals Says On April 17, Co, Unit And SVB Entered Loan And Security Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Dova Pharmaceuticals Inc:\n* DOVA PHARMACEUTICALS-ON APRIL 17, CO, UNIT AND SVB ENTERED LOAN AND SECURITY AGREEMENT,PURSUANT TO WHICH SVB AGREED TO LEND CO, UNIT OF $20.0 MILLION\n* DOVA PHARMA SAYS LOAN MATURES ON APRIL 17, 2021 UNLESS CO ACHIEVES SPECIFIED REVENUE MILESTONE, THEN MATURITY DATE TO BE EXTENDED BY A YEAR - SEC FILING Source text: ( bit.ly/2JdeQ1h ) Further company coverage:\n ",
    "published": "2018-04-20T20:00:00.000+03:00",
    "crawled": "2018-04-21T18:14:21.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "dova",
        "pharmaceutical",
        "inc",
        "dova",
        "april",
        "co",
        "unit",
        "svb",
        "entered",
        "loan",
        "security",
        "agreement",
        "pursuant",
        "svb",
        "agreed",
        "lend",
        "co",
        "unit",
        "million",
        "dova",
        "pharma",
        "say",
        "loan",
        "matures",
        "april",
        "unless",
        "co",
        "achieves",
        "specified",
        "revenue",
        "milestone",
        "maturity",
        "date",
        "extended",
        "year",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}